We evaluated the effect of DSC2 on the metastasis of GC in clinical GC specimens, GC cells with DSC2 knockdown and stably overexpression, and mouse metastasis models and aimed to distinguish a novel target for GC treatment. This evidence concerns the gene DSC2 and gastric cancer.